POZ September 2017
POZ September 2017
In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Features
Close To You
Aging with HIV doesn’t have to mean living without love.
Making the Case for Equality
Lambda Legal fights for LGBT people and everyone living with HIV.
Moments of Stillness
Stephen Barker’s portraits show early AIDS activists, minus all the anger
Editor’s Letter
Open Your Heart
I remember very well how heartbroken I was after testing HIV positive.
POZ Q+A
Positive Access
The ADAP Advocacy Association seeks to protect the federally funded AIDS Drug Assistance Program.
POZ Planet
Spilling the T
Advice via a transgender documentary
The Website Formerly Known as AIDS.gov
AIDS.gov was recently rechristened to HIV.gov.
Outreach in Alabama
MAO turns 30.
Trump AIDS Advisers Quit
This summer, six members of the Presidential Advisory Council on HIV/AIDS resigned because President Trump “simply does not care.”
Drool-Worthy
Photography book Dogs & Daddies raises funds to help youth living with HIV.
Voices
Battle Scars
Glenna McCarthy makes the case that despite living with HIV, lipodystrophy and aging, she is at her best right now.
Spotlight
Long-Term Survivors
The social media buzz on Long-Term Survivor Awareness Day
Research Notes
Prevention: Criminalization
State laws that criminalize people who don’t first disclose their HIV status before potential exposure don’t appear to prevent transmission.
Treatment: Antibody Treatment
TaiMed Biologics has applied for approval of the weekly injectable antibody ibalizumab for people with multidrug-resistant virus.
Cure: CRISPR Gene Editing
For the first time, scientists have used the powerful, cutting-edge CRISPR/Cas9 gene-editing method to snip HIV out of infected mice.
Concerns: Drinking Costs
Heavy drinking may be quite hazardous to HIV-positive people.
Care And Treatment
Life Expectancy Is Looking Up
Continued improvements in ARVs have likely further raised life expectancy for the average 20-year-old who starts treatment today.
Generic Truvada?
The Food and Drug Administration recently approved a generic formulation of Gilead Sciences’ antiretroviral Truvada.
Shifting Cancer Burden
As the HIV population ages, the cancer burden will shift away from those associated with AIDS and toward those connected to aging.
HIV + Hep C = Raised Cancer Risk
People who are living with both HIV and hepatitis C virus (HCV) have a higher risk of developing non-AIDS-defining cancers.
Heroes
Educating the People
Gloria Searson has been fighting to end the epidemic in New York City for almost 25 years.
Survey
Take Care
September 2017 Survey
